Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...
Rocket Pharmaceuticals ( ($RCKT) ) has shared an announcement. On October 14, 2025, Rocket Pharmaceuticals announced that the FDA accepted the ...
FDA accepts Rocket Pharmaceuticals' resubmission for Kresladi gene therapy in severe LAD-I, with a decision expected by March ...
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...
Rocket Pharmaceuticals (RCKT) stock jumps as FDA accepts the company's resubmitted marketing application for Kresladi gene therapy for review. Read more here.
FA is an inherited syndrome that impairs the body's chromosomal repair systems, causing the bone marrow to lose its ability ...
Oriole is a Proven Hypersonic, Ballistic Missile Target and “Other” Mission SRM System Kratos’ Rocket Systems and Hypersonics ...
YouTube on MSN
Leo battles the Jonsplus i100 Pro Chassis
Today Leo takes a look at the Jonsplus i100 Pro Mini itx chassis, priced around the 160 mark in the UK. Worth the cost? Leo ...
As the above video from Cheddar illustrates, the implementation of a corn maze is a marriage between technology and organic ...
Québec’s leading AI institute says it’s in the early stages of creating a potential VC fund to turn more of its research ...
Kratos leads in defense tech with strong growth and contracts, but slim margins and high valuation limit upside for now. Read ...
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback